Warp Drive Bio revises senior management

Massachusetts-based Warp Drive Bio, a life sciences company using proprietary genomic technology to transform the discovery and development of natural product drugs, has appointed the company's co-founder Dr Gregory Verdine CEO, succeeding Alexis Borisy who will remain on the board and assume the position of executive chair. Dr Verdine previously served as the Erving Professor of Chemistry in the Harvard University Departments of Stem Cell and Regenerative Biology, Chemistry and Chemical Biology, and Molecular and Cellular Biology for 25 years. Aside from Warp Drive Bio, Dr Verdine has co-founded multiple biotechs, including Enanta Pharmaceuticals, Eleven Biotherapeutics and Tokai Pharmaceuticals.

In addition to Dr Verdine's appointment, Warp Drive Biohas appointed Dr James Nichols to the newly created role of chief...